<DOC>
	<DOC>NCT01845272</DOC>
	<brief_summary>This study is designated to evaluate the pharmacokinetic interactions of candesartan cilexetil and amlodipine besylate in healthy male volunteers.</brief_summary>
	<brief_title>Pharmacokinetic Interactions of Candesartan Cilexetil and Amlodipine Besylate</brief_title>
	<detailed_description />
	<mesh_term>Candesartan</mesh_term>
	<mesh_term>Candesartan cilexetil</mesh_term>
	<mesh_term>Amlodipine</mesh_term>
	<criteria>Male volunteers in the age between 20 and 55 years old(inclusive) Body mass index (BMI) in the range of 18.5 to 27 kg/m2(inclusive) Available for the entire study period Understand the requirements of the study and voluntarily consent to participate in the study Subjects with a history of gastrointestinal diseases which might significantly change ADME of medicines Systolic blood pressure outside the range of 100 to 150 mmHg or diastolic blood pressure outside the range of 60 to 1000 mmHg for male subjects. when screening period Subject with symptoms of acute disease within 14days prior to study medication dosing Subjects with a history of clinically significant allergies Subjects with a hereditary problems, for example, galactose intolerance, Lapp lactase deficiency or glucosegalactose malabsorption Subjects whose clinical laboratory test values are outside the accepted normal range(Especially,AST or ALT &gt;1.5 times to normal range or total bilirubin &gt; 1.5times to normal range) History of drug abuse History of caffeine, alcohol, smoking abuse caffeine(coffee,tea,coke) or grapefruit juice &gt; 4cups/day smoking &gt; 20 cigarettes/day alcohol &gt; 140g/week Positive test results for HBs Ab, HCV Ab, Syphilis regain test Participation in any clinical investigation within 30days prior to study medication dosing Subjects with whole blood donation within 60days, component blood donation within 30days and blood transfusion within 30days prior to study medication dosing Subjects considered as unsuitable based on medical judgement by investigators</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>April 2013</verification_date>
</DOC>